11.10
price up icon1.98%   0.215
after-market After Hours: 11.10
loading
Precipio Inc stock is traded at $11.10, with a volume of 372. It is up +1.98% in the last 24 hours and up +40.86% over the past month. Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
See More
Previous Close:
$10.88
Open:
$11.1972
24h Volume:
372
Relative Volume:
0.04
Market Cap:
$17.22M
Revenue:
$15.81M
Net Income/Loss:
$-4.90M
P/E Ratio:
-3.2456
EPS:
-3.42
Net Cash Flow:
$-2.65M
1W Performance:
-2.55%
1M Performance:
+40.86%
6M Performance:
+94.65%
1Y Performance:
+91.05%
1-Day Range:
Value
$11.10
$11.20
1-Week Range:
Value
$10.50
$11.57
52-Week Range:
Value
$3.90
$11.80

Precipio Inc Stock (PRPO) Company Profile

Name
Name
Precipio Inc
Name
Phone
203 787 7888
Name
Address
12325 EMMET ST, OMAHA, CT
Name
Employee
60
Name
Twitter
@precipiodx
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
PRPO's Discussions on Twitter

Compare PRPO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
PRPO
Precipio Inc
11.10 17.22M 15.81M -4.90M -2.65M -3.42
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
390.26 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
195.75 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
520.59 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
116.09 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
154.10 27.64B 15.50B 1.33B 2.16B 7.34

Precipio Inc Stock (PRPO) Latest News

pulisher
Jun 17, 2025

Precipio Holds Annual Stockholders Meeting, Approves Proposals - TipRanks

Jun 17, 2025
pulisher
Jun 16, 2025

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting | PRPO Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Precipio, Inc. Urges Shareholders to Vote by 11 PM Today for Quorum at Upcoming Meeting - Nasdaq

Jun 16, 2025
pulisher
Jun 16, 2025

Precipio Shareholders Must Vote by 11PM Tonight: Company Risks $100K Extra Costs if Meeting Delayed - Stock Titan

Jun 16, 2025
pulisher
Jun 07, 2025

PRPOPrecipio Announces its Q1-2025 Financial Results - Revista ADVFN

Jun 07, 2025
pulisher
Jun 06, 2025

Precipio announces executive option grants tied to stock performance - MSN

Jun 06, 2025
pulisher
Jun 04, 2025

Transgenomic Inc. Reports Fourth Quarter and Fiscal Year 2003 Results - ADVFN

Jun 04, 2025
pulisher
May 28, 2025

Precipio, Inc. (NASDAQ:PRPO) Q1 2025 Earnings Call Transcript - MSN

May 28, 2025
pulisher
May 21, 2025

Director Makes Bold Move with Major Precipio Stock Purchase - TipRanks

May 21, 2025
pulisher
May 18, 2025

Precipio anticipates return to positive cash flow in Q2 or Q3 2025 amid robust margin gains and regulatory milestones - MSN

May 18, 2025
pulisher
May 17, 2025

(PRPO) Proactive Strategies - news.stocktradersdaily.com

May 17, 2025
pulisher
May 17, 2025

Precipio, Inc. (NASDAQ:PRPO) Q4 2024 Earnings Call Transcript - MSN

May 17, 2025
pulisher
May 16, 2025

Precipio’s Earnings Call: Cautious Optimism Amid Growth - TipRanks

May 16, 2025
pulisher
May 16, 2025

Precipio Inc (PRPO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Operational ... - Yahoo Finance

May 16, 2025
pulisher
May 16, 2025

Precipio Inc (PRPO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Operational Efficiency Amid Seasonal Challenges - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Precipio Inc Reports Q1 2025 Revenue of $4.9 Million and Improved Operational Efficiency - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Precipio Reports Strong Q1-2025 Revenue Growth - TipRanks

May 16, 2025
pulisher
May 15, 2025

Earnings call transcript: Precipio’s Q1 2025 shows revenue growth and stock surge - Investing.com Nigeria

May 15, 2025
pulisher
May 15, 2025

Precipio Announces its Q1-2025 Financial Results | PRPO Stock Ne - GuruFocus

May 15, 2025
pulisher
May 14, 2025

Precipio Earnings Report: Cancer Diagnostics Leader Posts 43% Revenue Growth, Targets Positive Cash Flow - Stock Titan

May 14, 2025
pulisher
May 14, 2025

Precipio Announces its Q1-2025 Financial Results | PRPO Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Precipio, Inc. Reports Strong Q1-2025 Financial Performance with 43% Revenue Growth - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Precipio Announces Its Q1-2025 Financial Results - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Precipio Announces its Q1-2025 Financial Results - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Precipio Announces its Q1-2025 Financial Results - GlobeNewswire Inc.

May 14, 2025
pulisher
May 14, 2025

Precipio, Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 08, 2025

Renaissance Technologies LLC Invests $56,000 in Precipio, Inc. (NASDAQ:PRPO) - Defense World

May 08, 2025
pulisher
May 06, 2025

Precipio Schedules Q1-2025 Shareholder Update Call - TipRanks

May 06, 2025
pulisher
May 02, 2025

Precipio Announces Q1-2025 Shareholder Update Call | PRPO Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Precipio, Inc. (NASDAQ:PRPO) Short Interest Update - Defense World

May 02, 2025
pulisher
May 01, 2025

Precipio Announces Q1-2025 Shareholder Update Call - The Globe and Mail

May 01, 2025
pulisher
May 01, 2025

Cancer Diagnostics Leader Precipio Sets Q1 2025 Earnings Call: How to Join Live Update - Stock Titan

May 01, 2025
pulisher
Apr 30, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 30, 2025
pulisher
Apr 29, 2025

Precipio (NASDAQ:PRPO) Shares Cross Below 200-Day Moving Average – Should You Sell? - Defense World

Apr 29, 2025
pulisher
Apr 25, 2025

Why Coursera Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 25, 2025
pulisher
Apr 22, 2025

The Zacks Analyst Blog Highlights Visa, ServiceNow, The Progressive, The Monarch Cement and Precipio - Yahoo

Apr 22, 2025
pulisher
Apr 21, 2025

Trading (PRPO) With Integrated Risk Controls - news.stocktradersdaily.com

Apr 21, 2025
pulisher
Apr 21, 2025

Top Research Reports for Visa, ServiceNow & Progressive - Yahoo Finance

Apr 21, 2025
pulisher
Apr 10, 2025

Precipio Appoints CBIZ as New Auditor Following Marcum Resignation By Investing.com - Investing.com Canada

Apr 10, 2025
pulisher
Apr 10, 2025

Precipio Appoints CBIZ as New Auditor Following Marcum Resignation - Investing.com Australia

Apr 10, 2025
pulisher
Apr 05, 2025

When (PRPO) Moves Investors should Listen - news.stocktradersdaily.com

Apr 05, 2025
pulisher
Apr 05, 2025

Precipio COO Ahmed Zaki Sabet acquires shares worth $473 By Investing.com - Investing.com India

Apr 05, 2025
pulisher
Apr 04, 2025

Precipio COO Ahmed Zaki Sabet acquires shares worth $473 - Investing.com

Apr 04, 2025
pulisher
Apr 02, 2025

Precipio Inc (PRPO) Q4 2024 Earnings Call Highlights: Break-Even Achieved and Strategic Growth ... - Yahoo

Apr 02, 2025
pulisher
Apr 02, 2025

Precipio Inc (PRPO) Q4 2024 Earnings Call Highlights: Break-Even Achieved and Strategic Growth Initiatives Unveiled - GuruFocus

Apr 02, 2025
pulisher
Apr 01, 2025

Precipio’s Earnings Call: Growth Amid Challenges - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Precipio Reports Positive Q4 Financial Results - TipRanks

Apr 01, 2025

Precipio Inc Stock (PRPO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research DGX
$178.95
price down icon 1.71%
diagnostics_research WAT
$341.10
price down icon 1.93%
diagnostics_research LH
$259.45
price down icon 1.71%
$167.55
price down icon 0.42%
diagnostics_research MTD
$1,150.57
price down icon 2.73%
diagnostics_research IQV
$154.10
price down icon 3.23%
Cap:     |  Volume (24h):